All stock lists
Beta Bionics, Inc. (NASDAQ:BBNX)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
20.32+1.16 (+6.07%)
Insider Score
––Not scored
BBNX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
BBNX analyst forecast
BBNX analyst consensus
Moderate Buy4 ratings
Buy 2 Hold 2 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
BBNX 12-month price target
$27.50+35.1% upsideaverage of 4 firms
$30.00High
$23.00Low
Best analysts covering BBNX
- Truist Securities0%success rate · 2 calls
- Goldman Sachs0%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
BBNX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Jefferies | — | $30.00 | +70.2% | — | 2026-10-12 | |
| Barclays | — | $30.00 | +61.0% | — | 2026-10-06 | |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-09-24 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-09-15 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-09-15 |
| — | Baird | Neutral | — | — | Reiterated | 2026-09-15 |
| Truist Financial | — | $23.00 | +37.5% | — | 2026-09-15 | |
| Leerink Partners | Outperform | $27.00 | +54.0% | Reiterated | 2026-09-14 | |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-07-15 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-07-13 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-05-27 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-05-18 |
| — | Stifel | Buy | — | — | Reiterated | 2026-04-22 |
| — | Leerink Partners | Outperform | — | — | Reiterated | 2026-04-22 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-04-15 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-04-09 |
| — | Stifel | Buy | — | — | Reiterated | 2026-02-18 |
| — | Baird | Neutral | — | — | Reiterated | 2026-02-18 |
| — | Stifel | Buy | — | — | Reiterated | 2026-02-04 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-02-02 |
| — | Lake Street | Buy | — | — | Reiterated | 2026-01-09 |
| — | B of A Securities | Buy | — | — | Reiterated | 2026-01-05 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-12-18 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-10-29 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-10-29 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-10-29 |
| — | Stifel | Buy | — | — | Reiterated | 2025-10-29 |
| — | Goldman Sachs | Buy | — | — | Upgraded | 2025-10-01 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-09-22 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-07-30 |
| — | Baird | Neutral | — | — | Reiterated | 2025-07-30 |
BBNX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-17 | -0.42 | -0.30 | $30.4M | $32.1M |
| 2026-04-21 | -0.53 | -0.49 | $26.9M | $27.6M |
| 2026-07-29 | -0.58 | -0.53 | $31.5M | $32.0M |
| 2026-10-27 | -0.52 | 0.00 | $34.7M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.